UPDATE 1-Celldex vaccine improves long-term brain cancer survival in study
November 20, 2015 at 15:50 PM EST
Nov 20 (Reuters) - New data from a midstage trial show that Celldex Therapeutics Inc's experimental brain cancer vaccine, combined with standard therapy, continues to improve chances of survival for patients with recurrent cancer.
